What 13 Analyst Ratings Have To Say About DocuSign
Portfolio Pulse from Benzinga Insights
In the last three months, 13 analysts have published diverse ratings on DocuSign (NASDAQ:DOCU), with recent updates showing a mix of opinions. The average 12-month price target has been raised to $64.62, indicating a 21.65% increase from the previous target. Analysts' actions, including maintaining, raising, and lowering ratings, reflect their current views on the company's performance and market conditions. DocuSign's financial health is analyzed, highlighting its market capitalization, revenue growth, net margin, ROE, ROA, and debt management. The company's Agreement Cloud offers a suite for automating agreements and providing e-signatures.
March 08, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DocuSign's stock may see short-term movements based on the mixed analyst ratings and the raised 12-month price target. The company's financial health, including revenue growth and challenges in profitability and debt management, could influence investor sentiment.
The raised average price target suggests a positive outlook from analysts, which could lead to increased investor confidence and a potential rise in DOCU's stock price. However, the mixed ratings and financial challenges highlighted may temper expectations, making the overall impact likely positive but with caution.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100